For Remedy Entertainment, CONTROL Resonant represents something more consequential than a successful sequel. It is the company's largest attempt to combine ownership of a major franchise with direct publishing responsibility, and its first financial results show both the potential and the costs of that strategy.
Revenue reached €39.6 million in the third quarter of 2026, compared with €12.2 million a year earlier. The 226% increase was primarily driven by CONTROL Resonant preorders and the game's first seven days of digital sales.
The launch took place on September 24. By October 15, worldwide sales had exceeded one million units, making Resonant the fastest-selling game in Remedy's 31-year history. That milestone arrived after the reporting period, meaning the quarterly results capture only a fraction of the game's initial commercial life.
Publishing ownership changes the financial equation
Remedy's previous successes have often relied on partnerships with major publishers. The company created Max Payne before working with Rockstar Games, developed games with Microsoft, and collaborated with Epic Games Publishing on Alan Wake 2.
CONTROL Resonant follows a different structure. Remedy owns the intellectual property and publishes the title itself, with Annapurna Pictures participating through a financing and co-production agreement.
This allows Remedy to recognize more of the revenue generated by game sales, while also taking greater responsibility for launch-related expenses and commercial execution.
The difference is visible in the latest figures. Game sales and royalties contributed €35.3 million to third-quarter revenue, while development fees accounted for another €4.3 million.
Operating profit was €0.6 million, compared with a €16.4 million loss in the equivalent quarter of 2025. Although the turnaround is substantial, the operating margin reached only 1.5%. Marketing investment, publishing costs and depreciation of capitalized development expenditure all affect the profitability of a major launch.
The headline revenue increase is therefore best understood as evidence of stronger commercial scale, not proof that Remedy has already established high operating margins through self-publishing.
A franchise built beyond its original audience
The sales record was achieved in just three weeks, but Remedy's audience analysis may be equally relevant to its long-term plans. Internal data suggests that nearly 50% of CONTROL Resonant players are newcomers to the franchise.
The sequel changes several features of the original game's identity. Dylan Faden takes over from his sister Jesse as the central character, Manhattan replaces the confined institutional environment as the main setting, and melee-oriented combat plays a much larger role.
Those creative decisions also serve a commercial purpose. Remedy designed Resonant as an accessible entry point rather than a sequel aimed exclusively at players already familiar with Control's mythology.
Expanding the audience gives the company more flexibility when considering future releases set in the same fictional universe. The studio now describes Control as an established franchise rather than a single successful original game.
The United States remains the dominant market, accounting for nearly half of all sales. On PC, Chinese-speaking regions and the United Kingdom were significant secondary territories. Console sales also showed notable demand in the United Kingdom, Canada and Brazil.
Wishlists are an opportunity, not a sales forecast
Remedy reports approximately 2.4 million outstanding wishlists for CONTROL Resonant. The figure demonstrates continuing interest beyond the initial purchasing audience, but it cannot be interpreted as a guaranteed number of additional sales.
Wishlist conversion depends on pricing, marketing, competition, platform promotions and individual purchasing decisions. Remedy intends to support future demand through targeted campaigns while maintaining discipline over promotional spending.
The company has also highlighted favorable player reception. As of November 2, Steam user reviews were 91% positive, while PlayStation 5 users had given the game an average rating of 4.7 out of 5. Remedy reported an 83 combined Metacritic critic rating.
These indicators are helpful for judging the game's initial reception, although long-term commercial performance will depend on how the audience develops after launch.
The annual figures still leave work to do
The third-quarter turnaround looks particularly strong when viewed in isolation. Across the first nine months of 2026, however, Remedy generated €62.9 million in revenue and still recorded an operating loss of €2.3 million.
That broader picture includes development spending, marketing expenditure and the consequences of previous releases. FBC: Firebreak, which did not achieve the commercial momentum Remedy initially sought, remains part of the context for the company's evolving publishing strategy.
Remedy continues to develop the Max Payne 1 & 2 remake for Rockstar Games, while supporting its existing Alan Wake and Control catalogues. These activities provide different revenue streams and reduce reliance on a single launch.
CONTROL Resonant now gives the self-publishing business a meaningful commercial foundation. But the next stage is less about setting another launch record and more about sustaining demand while managing the costs attached to publishing large games independently.
Remedy's management has made that distinction explicit. Sales during the remainder of 2026 will ultimately determine the company's full-year financial outcome.
